These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30689556)
1. Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis. Shi S; Tian B Cancer Biomark; 2019; 24(2):183-193. PubMed ID: 30689556 [TBL] [Abstract][Full Text] [Related]
2. Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses. Li P; Cao J; Li J; Yao Z; Han D; Ying L; Wang Z; Tian J Cancer Med; 2020 Oct; 9(19):7253-7267. PubMed ID: 32786144 [TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis. Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer. Lin YZ; Wu YP; Ke ZB; Cai H; Chen DN; Chen SH; Li XD; Lin TT; Huang JB; Zheng QS; Xue XY; Xu N; Wei Y Med Sci Monit; 2020 Apr; 26():e920504. PubMed ID: 32277695 [TBL] [Abstract][Full Text] [Related]
5. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
6. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis. Feng Y; Jiang Y; Wen T; Meng F; Shu X Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911 [TBL] [Abstract][Full Text] [Related]
7. Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer. Shi J; Zhang P; Liu L; Min X; Xiao Y Mol Genet Genomic Med; 2019 Nov; 7(11):e982. PubMed ID: 31566930 [TBL] [Abstract][Full Text] [Related]
8. Song DM; Shen T; Feng K; He YB; Chen SL; Zhang Y; Luo WF; Han L; Tong M; Jin Y Front Immunol; 2024; 15():1419126. PubMed ID: 39234248 [TBL] [Abstract][Full Text] [Related]
9. Identifying the mRNAs associated with Bladder cancer recurrence. Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597 [TBL] [Abstract][Full Text] [Related]
10. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W Hereditas; 2019; 156():24. PubMed ID: 31333338 [TBL] [Abstract][Full Text] [Related]
11. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer. Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362 [TBL] [Abstract][Full Text] [Related]
12. Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy. Cao W; Ma E; Zhou L; Yuan T; Zhang C World J Surg Oncol; 2017 Mar; 15(1):66. PubMed ID: 28320388 [TBL] [Abstract][Full Text] [Related]
13. Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer. Bi D; Ning H; Liu S; Que X; Ding K Comput Biol Chem; 2015 Jun; 56():71-83. PubMed ID: 25889321 [TBL] [Abstract][Full Text] [Related]
14. Co-expression network analysis identified atypical chemokine receptor 1 (ACKR1) association with lymph node metastasis and prognosis in cervical cancer. Liu J; Li S; Lin L; Jiang Y; Wan Y; Zhou S; Cheng W Cancer Biomark; 2020; 27(2):213-223. PubMed ID: 32083574 [TBL] [Abstract][Full Text] [Related]
15. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis. Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274 [TBL] [Abstract][Full Text] [Related]
16. Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data. Xu Y; Wu G; Li J; Li J; Ruan N; Ma L; Han X; Wei Y; Li L; Zhang H; Chen Y; Xia Q Biomed Res Int; 2020; 2020():8283401. PubMed ID: 32047816 [TBL] [Abstract][Full Text] [Related]
17. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods. Li C; Zeng X; Yu H; Gu Y; Zhang W World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899 [TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis. Kong J; Shen S; Zhang Z; Wang W Cancer Biomark; 2020; 27(4):505-517. PubMed ID: 32116234 [TBL] [Abstract][Full Text] [Related]
19. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma. Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337 [TBL] [Abstract][Full Text] [Related]
20. Identification of several cell cycle relevant genes highly correlated with the progression and prognosis of human bladder urothelial tumor. Wang L; Chen S; Luo Y; Yuan L; Peng T; Qian K; Liu X; Xiao Y; Wang X J Cell Physiol; 2019 Aug; 234(8):13439-13451. PubMed ID: 30618079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]